Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 11NIH 4INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Other neoplasm 1

Conditions

Neoplasms 5Uterine Cervical Neoplasms 3Breast Neoplasms 3Uterine Cervical Dysplasia 2Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Melanoma 2Lung Neoplasms 2Kidney Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Skin Neoplasms 1Sarcoma, Endometrial Stromal 1Precancerous Conditions 1Neoplasms by Site 1Neoplasm Metastasis 1Liver Neoplasms 1Leiomyosarcoma 1Leiomyoma 1Head and Neck Neoplasms 1Genital Neoplasms, Female 1Genital Diseases, Female 1Genital Diseases 1Female Urogenital Diseases and Pregnancy Complications 1Endometrial Neoplasms 1Colorectal Neoplasms 1

Interventions

pembrolizumab 44Carboplatin 28Cisplatin 26Paclitaxel 24Bevacizumab 21human papillomavirus vaccine, L1 type 16, 18 16Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14atezolizumab 11Papillomavirus Vaccines 11Nivolumab 10tisotumab vedotin 8Vaccines, Synthetic 8Gemcitabine 8Colposcopy 8Topotecan 7fludarabine 6Vaccines 6Injections 6Cyclophosphamide 6spartalizumab 5balstilimab 5Pemetrexed 5Irinotecan 5Fulvestrant 5Docetaxel 5zimberelimab 4durvalumab 4Vinorelbine 4Ipilimumab 4Interleukin-2 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Uterine Cervical Neoplasms × Biopsy × Clear all
NCT07211204 2026-03-03

Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population

Timser SAPI de CV

Phase NA Withdrawn
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Atypical Squamous Cells of the Cervix

NCT06815939 2026-01-29

OPTICS

DL Analytics

Phase NA Recruiting
10,000 enrolled
GynecologicOther neoplasm

Urogenital Diseases, Genital Diseases, Uterine Cervical Diseases, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Precancerous Conditions, Urogenital Neoplasms, Uterine Diseases, Uterine Neoplasms

NCT03020121 2018-01-31

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

Becton, Dickinson and Company

Phase NA Terminated
28 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡